FibroBiologics, Inc. (FBLG) Operating cash flow 2022–2025
FibroBiologics, Inc. (FBLG) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$16.4MFY2025 · since FY2022: -$4.1M → -$16.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.4M | -37.8% |
| FY2024 | -$11.9M | -85.9% |
| FY2023 | -$6.4M | -57.4% |
| FY2022 | -$4.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice